Article Details

Amgen/AstraZeneca's Asthma Drug Misses Phase III Study Goal

Retrieved on: 2020-12-23 15:33:45

Tags for this article:

Click the tags to see associated articles and topics

Amgen/AstraZeneca's Asthma Drug Misses Phase III Study Goal. View article details on hiswai:

Excerpt

Amgen and AstraZeneca plan to file regulatory applications for tezepelumab next year. This year so far, AstraZeneca's shares have declined 2.3% ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up